← Back to screener

ALX ONCOLOGY HOLDINGS INC ALXO

Rank #1739 · Nasdaq · $0.2B market cap
Audited by KPMG LLP, no going-concern flag in the latest filing.
Score
43.1
P/E
-1.0
P/B
0.62
ROE
-61.0%
Op. Margin
–%
Debt Ratio
13%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E -1.0x, P/B 0.62x. Ranks in the top 52% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -61.0%. Ranks in the top 90% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 13%. Ranks in the top 10% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2020$0.0B$-0.0B$-0.0B$-0.0B-662.0-29
2021$0.0B$-0.0B$-0.0B$-0.1B-400.0-12
2022$0.0B$-0.0B$-0.0B$-0.1B-3694.0-24
2023–$-0.1B$-0.1B$0.4B–10
2024–$-0.1B$-0.1B$0.4B–15
2025–$-0.2B$-0.2B$0.3B–13

← See the full screener